With low-concentration vapes becoming S3 from 1 October 2024, there is much confusion as to what is expected of pharmacists, and how the market is likely to play out.

Liber Pharmaceuticals has worked closely with thousands of pharmacists and prescribers for the last three years to ensure that you are able to supply therapeutic vapes effectively.

Join us as we share our thoughts on the following:

• What the new regulations mean for pharmacists and prescribers
• Learnings from the first three years of prescribed vaping
• Mitigating risks associated with the supply of S3 vapes
• Practical advice on how you can be ready for 1 October

Each session will have at least 30 minutes for Q&A.